Introduction
============

The extensive use of antibiotics in human treatment and agriculture has led to the development of one of the greatest problems faced by modern medicine: multidrug-resistant bacteria. Resistance may arise via various mechanisms including changes in cell-wall permeability, target site mutation, antibiotic inactivation and the development of efflux pumps that transport the drugs out of the cell \[[@R1]--[@R2]\]. Clearly, the development of new types of antibiotics is strongly needed \[[@R3]\].

Flavonoids are a diverse class of plant secondary metabolites that share the same C~6~--C~3~--C~6~ backbone. The great structural diversity of these compounds results in a wide range of biological activities. Flavonoids can display antibacterial, antiviral, antifungal, anti-inflammatory and anticancer properties \[[@R4]--[@R10]\]. Their polyphenolic structure also gives them excellent anti-oxidant and cardioprotective properties \[[@R11]--[@R12]\].

Our research group has recently reported the antibacterial properties of a new class of synthetic tricyclic flavonoids \[[@R13]\]. Given the promising results that have been obtained for compound **1** ([Fig. 1](#F1){ref-type="fig"}), we chose this compound for a structure--activity study. For this purpose we initially decided to retain the halogen substituents of the aromatic A and B rings, while changing the nature of the dialkylamino moiety at the 2 position of ring D. After the best correlation between the antibacterial activity and the nature of the dialkylamino moiety had been identified as the *N*,*N*-diethylamino group, this substituent was maintained, while the structure--activity study was extended to different halogen substituents of the A and B rings. This paper presents the results obtained, using this strategy against *Staphylococcus aureus* and *Escherichia coli*.

![The molecular structure of tricyclic flavonoid **1**.](Beilstein_J_Org_Chem-12-1065-g002){#F1}

Results and Discussion
======================

Chemistry
---------

The synthesis of the desired compounds was achieved using a method previously employed by us \[[@R14]--[@R18]\] through the reaction of phenacyl carbodithioates **2a**--**f** with aminals **3a**--**e** as presented in [Scheme 1](#C1){ref-type="fig"}.

![Synthesis of flavanones **4a**--**m** and tricyclic flavonoids **5a**--**m**. Conditions: i) EtOH, reflux, 4 h; ii) H~2~SO~4~/CH~3~COOH (1:3 v/v), 20 min; iii) NaBF~4~ aq.](Beilstein_J_Org_Chem-12-1065-g006){#C1}

Phenacyl carbodithioates **2a**--**f**, obtained from the appropriately substituted ω-bromoacetophenones and ditihiocarbamates according to previously described procedures \[[@R19]--[@R20]\], and aminals **3a**--**e**, synthesized by reacting morpholine with halogenated benzaldehydes \[[@R21]--[@R22]\], are collected in [Table 1](#T1){ref-type="table"}. The individual substitution patterns and yields for flavonoids **4a**--**m** and **5a**--**m** are presented in [Table 2](#T2){ref-type="table"}.

###### 

Phenacyl carbodithioates **2a**--**f** and halogenated aminals **3a**--**e**.

  ----------- -------- ------------- ------------ -------- -------- -------- ----
              **a**    **b**         **c**        **d**    **e**    **f**    
                                                                             
  **2**       R^1^     Br            Br           Br       Br       I        H
  NR^2^ ~2~   NMe~2~   pyrrolidine   piperidine   NEt~2~   NEt~2~   NEt~2~   
                                                                             
  **3**       R^3^     F             Cl           Br       I        H        --
  ----------- -------- ------------- ------------ -------- -------- -------- ----

###### 

Substitution patterns and yields for flavonoids **4a**--**m** and **5a**--**m**.

  ------- -------------- ------ ------------- ------ ------------------- -------------------
  Entry   **4**, **5**   R^1^   NR^2^ ~2~     R^3^   Yield of **4**, %   Yield of **5**, %
                                                                         
  1       **a**          Br     NMe~2~        Cl     45                  48
  2       **b**          Br     pyrrolidine   Cl     92                  77
  3       **c**          Br     piperidine    Cl     87                  70
  4       **d**          Br     NEt~2~        F      85                  86
  5       **e**          Br     NEt~2~        Br     87                  88
  6       **f**          Br     NEt~2~        I      48                  87
  7       **g**          Br     NEt~2~        H      62                  77
  8       **h**          I      NEt~2~        F      70                  68
  9       **i**          I      NEt~2~        Cl     84                  72
  10      **j**          I      NEt~2~        Br     73                  56
  11      **k**          I      NEt~2~        I      82                  62
  12      **l**          I      NEt~2~        H      62                  64
  13      **m**          H      NEt~2~        H      85                  61
  ------- -------------- ------ ------------- ------ ------------------- -------------------

The reaction between brominated and iodinated phenacyl carbodithioates **2a**--**f** and halogenated aminals **3a--e** lead to the formation of flavanones **4a**--**m** as a mixture of diastereomers. These differ in the orientations of the H2 and H3 hydrogen atoms, which may be on the same side or on opposite sides of the ring C ([Fig. 2](#F2){ref-type="fig"}).

![The *syn* and *anti*-isomers of flavanones **4**.](Beilstein_J_Org_Chem-12-1065-g003){#F2}

The outcome of the reaction was confirmed by analytical data and spectroscopical methods. The ^1^H NMR spectra of flavanones **4** all indicate the disappearance of the singlet corresponding to the methylene unit bound to the carbonyl group (\~4.8 ppm). Moreover, the signal belonging to the phenolic hydrogen atom, present in the phenacyl carbodithioate ^1^H NMR spectra at ca. 12 ppm, is no longer present in the flavanone spectra. Two new sets of doublets, one from the *syn* and one from the *anti*-isomer, appear between 5 ppm and 6 ppm and correspond to the hydrogen atoms H2 and H3. These isomers can be distinguished by calculating the coupling constants, which are found to be ca. 4 Hz for the *syn* and ca. 9 Hz for the *anti*-isomers.

New signals in the aromatic region of the ^13^C NMR spectra reveal the incorporation of aromatic ring B. The EIMS spectra display the molecular ions as well as a number of characteristic fragments. For flavanones **4d**--**m** fragments formed by cleavage of the S--(CS) bond of the *N*,*N*-diethyldithiocarbamic moiety are observed. In fact, the most intense signals in the spectra belongs to the \[C~5~H~10~NS\]^+^ fragment at *m*/*z* = 116.1. Another common fragment at *m*/*z* = 148.0 corresponding to \[C~5~H~10~NS~2~\]^+^ originates from the cleavage of the C(3)--S bond in these compounds. For flavanones **4d** and **4f** crystals suitable for single crystal X-ray analysis were obtained and the results are discussed in the X-ray analysis section.

The acid-catalyzed cyclocondensation of flavanones **4a**--**m** afforded the tricyclic flavonoids **5a**--**m** in good yields \[[@R23]\] ([Scheme 1](#C1){ref-type="fig"}). The formation of the 1,3-dithiolium ring is associated with characteristic spectral changes. Thus, in the ^1^H NMR spectra of flavonoids **5** the signal belonging to the hydrogen atom from the 2 position of ring C is shifted to ca. 6.85--6.95 ppm and its multiplicity changes from a doublet to a singlet. The ^13^C NMR spectra indicate the disappearance of the carbonyl and thiocarbonyl signals (ca. 191 ppm and 186 ppm) and a new signal at ca. 184 ppm appears, belonging to the positive carbon atom of the 1,3-dithiolium ring. The IR spectra of the tricyclic flavonoids **5** lack the carbonyl absorption band (ca. 1690--1680 cm^−1^) and the presence of a new broad absorption band at around 1040 cm^−1^ is attributed to the tetrafluoroborate anion. ESIMS confirms the structure of the positive molecular fragment of each tricyclic flavonoid (\[M − BF~4~\]^+^). Single crystals suitable for X-ray analysis were obtained for **5a** and **5b** and the results are presented in the X-ray section below.

X-ray analyses
--------------

The crystal structures of flavanones **4d** and **4f** are presented in [Fig. 3](#F3){ref-type="fig"}.

![Molecular structures of **4d** (left) and **4f** (right). Ellipsoids represent 50% probability levels \[[@R24]\].](Beilstein_J_Org_Chem-12-1065-g004){#F3}

We found that compounds of general structure **4**, despite their close chemical similarity, display conformational differences, especially regarding the ethyl groups. Relevant torsion angles for **4d** and **4f** are shown in [Table 3](#T3){ref-type="table"} and are generally consistent with previously observed values (indeed, **4d** is isotypic to the compound with R^1^ = R^3^ = Cl \[[@R25]\]), except that **4f** shows some extreme values for ring C. Compounds **4e** and **4k** were also investigated; **4e** is isotypic to **4f** according to its cell constants (the structure was not determined), whereas **4k** proved to be seriously disordered.

###### 

Selected torsion angles (°, rounded to nearest degree) for **4d** and **4f**.

  -------------------------------- ------------ ----------
                                   **4d** ^a^   **4f**

                                                

  O1--C2--C11--C16                 49           41

  C3--S1--C17--S2                  −2           23

  C17--N1--C~ethyl~--C~ethyl~      −98, −89     −91, −89

  C10--O1--C2--C3                  −44          −59

  O1--C2--C3--C4                   53           51

  C2--C3--C4--C5                   −35          −18

  C3--C4--C5--C10                  8            −8

  C4--C5--C10--O1                  2            3

  C5--C10--O1--C2                  17           32

  Ring C10--O1--C2--C3--C4--C5,\   27           29
  mean absolute torsion angle                   
  -------------------------------- ------------ ----------

^a^Inverted from deposited coordinates.

The crystal structures of tricyclic flavonoids **5a** and **5b** are displayed in [Fig. 4](#F4){ref-type="fig"}. Both compounds crystallize with two independent molecules in the asymmetric unit. The main possible degrees of freedom involve the ring orientations and the torsion angles of the heterocyclic ring C, although, in contrast to compounds **4**, the latter are constrained by the presence of the double bond C3=C4. Selected torsion angles are collected in [Table 4](#T4){ref-type="table"}, and show similar values for all four molecules, except for a flattening of the heterocyclic ring in **5a**.

![Molecular structure of **5a** (left, both independent molecules) and **5b** (right, one of two independent molecules). Ellipsoids represent 50% probability levels \[[@R26]\].](Beilstein_J_Org_Chem-12-1065-g005){#F4}

###### 

Selected torsion angles (°, rounded to nearest degree) for **5a** and **5b**.

  ------------------ ------------ --------------
                     **5a**       **5b** ^a^
                                  
  O1--C2--C9--C10    −132, −118   −124, −131
  S1--C15--N1--C17   1, 4         178, −177^b^
  O1--C2--C3--C4     23, 31       36, 39
  C2--C3--C4--C4A    −2, −5       −5, −7
  C3--C4--C4A--C8A   −12, −13     −14, −14
  C4--C4A--C8A--O1   4, 1         --1, --1
  C4A--C8A--O1--C2   19, 29       34, 33
  C8A--O1--C2--C3    −31, −43     −49, −51
  ------------------ ------------ --------------

^a^Inverted from deposited coordinates. ^b^S1--C15--N1--C19.

In vitro antibacterial activity
-------------------------------

The promising results obtained in our previous studies \[[@R13],[@R27]\] prompted us to investigate to what degree the amino moiety and the two halogen atoms bound to tricyclic flavonoids of type **5** influence their antibacterial activity. This study also established that dithiocarbamic flavanones of type **4** display no such activity. Therefore, only flavonoids **5a**--**m** were tested against *Staphylococus aureus* (Gram positive) and *Escherichia coli* (Gram negative) in an attempt to establish an antimicrobial structure--activity relationship. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) using the standard microbroth dilution technique were recorded and the results are collected in [Table 5](#T5){ref-type="table"}.

###### 

Minimum inhibitory concentrations and minimum bactericidal concentrations of flavonoids **5a**--**m** against *Staphylococcus aureus* and *Escherichia coli*.

  ---------------- ----------------------- ------------------ ---------------- ------- -------
  Entry            Flavonoid               Bacterial strain                            
  MIC (μg/mL)^a^   MBC (μg/mL)^b^                                                      
  *S. aureus*      *E. coli*               *S. aureus*        *E. coli*                
                                                                                       
  1                **5a**                  7.81               15.62            --^c^   --^c^
  2                **5b**                  1.95               3.90             --^c^   --^c^
  3                **5c**                  62.5               125              --^c^   --^c^
  4                **1**                   0.24               3.9 \[[@R13]\]   0.24    7.81
  5                **5d**                  1.95               15.62            1.95    15.62
  6                **5e**                  0.48               3.9              0.97    7.81
  7                **5f**                  0.48               3.9              1.95    7.81
  8                **5g**                  1.95               7.81             1.95    250
  9                **5h**                  1.95               7.81             1.95    15.62
  10               **5i**                  0.48               3.9              1.95    15.62
  11               **5j**                  0.48               3.9              1.95    7.81
  12               **5k**                  0.48               3.9              1.95    7.81
  13               **5l**                  0.97               7.81             7.81    62.5
  14               **5m**                  62.5               62.5             250     250
  15               kanamycin               1.95               7.81             1.95    7.81
  16               ampicillin              7.81               7.81             --^c^   --^c^
  17               control (DMSO, μL/mL)   250                125              --      --
  ---------------- ----------------------- ------------------ ---------------- ------- -------

^a^MIC = minimum inhibitory concentration. ^b^MBC = minimum bactericidal concentration. ^c^Not determined.

As mentioned above, we started the study with the synthesis and testing of tricyclic flavonoids **5a**--**d**, which differ from **1** in the amino group bound to the 1,3-dithiolium cycle (ring D). Upon testing these flavonoids against *Staphylococcus aureus* and comparing the results with those obtained for **1**, we concluded that the antibacterial activity for tricyclic flavonoids of type **5** decreases in the order NEt~2~ \> pyrrolidine \> NMe~2~ \> piperidine ([Table 5](#T5){ref-type="table"}, entries 1--4). These results suggest that a larger *N*,*N*-dialkylamino group leads to a decreased antibacterial activity, with compound **5c** showing an unexpectedly high MIC value in comparison to the other three compounds of this group.

Having established this, we synthesized diethylamino-substituted flavonoids **5d**--**m**. In order to investigate the influence of halogen substituents on the biological properties of tricyclic flavonoids, we first synthesized flavonoid **5m** (R^1^ = R^3^ = H) having no halogen substituents in the structure as a reference compound. The MIC and MBC values obtained for this compound against both *S. aureus* and *E. coli* are presented in [Table 5](#T5){ref-type="table"}, entry 14. In the next step, we synthesized and evaluated another two tricyclic flavonoids with bromine and iodine atoms bound to ring A, **5g** (R^1^ = Br, R^3^ = H) and **5l** (R^1^ = I, R^3^ = H). With this modification, promising results concerning biological activity were obtained ([Table 5](#T5){ref-type="table"}, entries 8 and 13). In comparison with **5m** which showed a MIC value of 62.5 μg/mL, these compounds presented minimum inhibitory concentrations of 7.81 μg/mL against *E. coli* and 0.97--1.95 μg/mL against *S. aureus.* The bactericidal properties of flavonoids **5g** and **5l** were also promising with the exception of compound **5g** against *E. coli* for which no bactericidal effect was observed (MBC = 250 µg/mL). These results clearly indicated the importance of halogen substituents for the antibacterial activity of this class of tricyclic flavonoids. Prompted by this observation, we decided to include other halogen-substituted compounds (R^3^ = F, Cl, Br, and I) in the study.

The MIC values obtained for flavonoids **5d** (R^1^ = Br, R^3^ = F), **5e** (R^1^ = Br, R^3^ = Br), **5f** (R^1^ = Br, R^3^ = I) ([Table 5](#T5){ref-type="table"}, entries 5--7) and **5h** (R^1^ = I, R^3^ = F), **5i** (R^1^ = I, R^3^ = Cl), **5j** (R^1^ = I, R^3^ = Br) and **5k** (R^1^ = I, R^3^ = I) ([Table 5](#T5){ref-type="table"}, entries 9--12) suggested that a bulkier halogen atom in the 4-position of ring B leads to an increased bacteriostatic activity against *S. aureus* and *E. coli.* The MIC values obtained against *E. coli* were the same (3.9 µg/mL) for all tricyclic flavonoids not containing a fluorine atom in their molecular structure. This suggests that the activity against Gram negative bacteria is less dependent on the nature of the introduced heavier halogen (Cl, Br or I).

Compound **1** was found to be slightly more potent against *S. aureus* in terms of bacteriostatic properties than the other tricyclic flavonoids and showed the lowest MIC of all tested compounds against this bacterial strain. With respect to bactericidal properties, the lowest value against *S. aureus* was again recorded for flavonoid **1**. The other seven newly synthesized tricyclic flavonoids also displayed good bactericidal properties against *S. aureus*, albeit they were less potent than **1**. Moreover, the halogen atoms present in their molecular structure did not greatly influence the MBC values; six out of the seven new flavonoids leading to the same result (exception **5e**, [Table 5](#T5){ref-type="table"}, entry 6). This also applies to the bactericidal activities determined against *E. coli*. The tricyclic flavonoids **5e**, **5f**, **5j** and **5k** ([Table 5](#T5){ref-type="table"}, entries 6, 7, 11 and 12) were comparably effective as compound **1** ([Table 5](#T5){ref-type="table"}, entry 4). The remaining three flavonoids, of which two contain fluorine (**5d** and **5h**, [Table 5](#T5){ref-type="table"}, entries 5 and 9), lead to slightly higher MBC values, suggesting once again that a smaller substituent leads to a lower antibacterial activity against Gram negative microorganisms.

In order to perform a comparison with known antibiotics, both *S. aureus* and *E. coli* where exposed to ampicillin and kanamycin ([Table 5](#T5){ref-type="table"}, entries 15 and 16). The results indicated that the newly synthesized tricyclic flavanoids exhibit similar or even better antimicrobial properties. However, due to the lack of cytotoxicity results one may assume that the investigated structures represent a promising class of compounds.

In summary, the newly synthesized compounds exhibit good to excellent antimicrobial properties against both Gram positive and Gram negative pathogens. The introduction of halogen substituents other than fluorine in the structures of the tricyclic flavonoids leads to a significant improvement of antibacterial properties. These results suggest that the substituent size is the main factor for the change in potency rather than polarity or electronical effects. As an important influence of the *N*,*N*-dialkylamino moiety on the antibacterial activity was observed, the extension of the study on the influence of other substituents is currently on the way.

Conclusion
==========

A previously reported class of tricyclic flavonoids has been extended with the synthesis of thirteen new derivatives. These compounds were obtained from the corresponding 3-dithiocarbamic flavanones under acidic conditions. A study of their structure--activity relationship was performed with regard to their antibacterial properties against *Staphylococcus aureus* and *Escherichia coli*. The introduction of halogen substituents in the structures of the tricyclic flavonoids leads to a significant improvement of antibacterial properties. These results suggest that the substituent size is the main factor for the change in potency rather than polarity or electronical effects. An important dependence on the nature of the *N*,*N*-dialkylamino substituent was observed. Working with *N*,*N*-diethylamino-substituted flavonoids, good to excellent antimicrobial properties were recorded against both pathogens.

Supporting Information
======================

###### 

Detailed experimental procedures, supplementary spectroscopic and X-ray data.
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